Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX)
SNDX Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
35.30%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
126.40%
SNDX Stock Analysis
SNDX
PE Ratio:
SNDX
PEG Ratio:
Not Available
SNDX
Forward EPS Growth (12 month):
0.00%
SNDX
PS Ratio:
7.5
SNDX
PSG Ratio:
0.2
SNDX
Forward Revenue Growth (12 month):
43.10%
SNDX Articles
No data was found